Analystreport

Histogenics Corp (NASDAQ: HSGX) had its price target raised by analysts at Needham & Company LLC to $5.00. They now have a "buy" rating on the stock.

HISTOGENICS CORP COMMON  (HSGX) 
Last histogenics corp common earnings: 8/9 04:11 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.histogenics.com